Drug Shortage Report for SUPREFACT

Last updated on 2022-05-25 History
Report ID 160170
Drug Identification Number 02225166
Brand name SUPREFACT
Common or Proper name Buserelin
Company Name CHEPLAPHARM ARZNEIMITTEL GMBH
Market Status MARKETED
Active Ingredient(s) BUSERELIN
Strength(s) 1MG
Dosage form(s) SOLUTION
Route of administration SUBCUTANEOUS SUBCUTANEOUS
Packaging size 5.5 mL / vial
ATC code L02AE
ATC description HORMONES AND RELATED AGENTS
Reason for shortage Delay in shipping of the drug.
Anticipated start date
Actual start date 2022-05-06
Estimated end date 2022-05-31
Actual end date 2022-05-24
Shortage status Resolved
Updated date 2022-05-25
Company comments
Health Canada comments
Tier 3 Status No
Contact Address ZIEGELHOF 24
GREIFSWALD, MECKLENBURG - WEST POMERANIA
GERMANY 17489
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2022-05-25 English Compare
v6 2022-05-24 French Compare
v5 2022-05-24 English Compare
v4 2022-05-07 English Compare
v3 2022-05-06 French Compare
v2 2022-05-06 English Compare
v1 2022-05-06 English Compare

Showing 1 to 7 of 7